Chunli Medical Reports Passing of Company Secretary; Board Addresses Resulting HKEX Non-Compliance

Bulletin Express
09/11

Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) announced that Mr. Ip Pui Sum, who served as Company Secretary, Authorised Representative under HKEX Listing Rule 3.05 and Process Agent under Rule 19A.13(2) and the Hong Kong Companies Ordinance, passed away on 10 September 2026. Mr. Ip had held these roles for a decade, during which he was recognised for his dedication and service.

The loss leaves Chunli Medical without a Company Secretary and Process Agent and with only one remaining Authorised Representative, resulting in non-compliance with HKEX Listing Rules 3.28, 3.05, 19A.13(2) as well as Section 474 and Part 16 of the Hong Kong Companies Ordinance. The board has initiated a search to appoint suitable successors “as soon as practicable” and will release further announcements when appointments are confirmed.

The board is chaired by Ms. Shi Wenling; current executive directors include Ms. Shi Wenling, Mr. Shi Chunbao, Ms. Yue Shujun and Mr. Xie Feng Bao. Mr. Wang Xin serves as non-executive director, and the independent non-executive directors are Ms. Xu Hong, Mr. Zheng Zhong Liang and Mr. Kwan King Nam.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10